Nodexus
San Francisco, United States · Founded 2014 · $31.2M raised
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Founded
- 2014
- Business Model
- B2B
- Website
- nodexus.com
- Total Funding
- $31.2M
- Last Round
- $30.0M Series ADec 2021
- Rounds
- 2
About
Nodexus is a UC Berkeley/Stanford StartX-backed biotech company commercializing single-cell sorting and dispensing technology for gene editing, drug development, and biological research. Its NX One instrument provides affordable, benchtop single-cell sorting starting under $100K.
Summary
Nodexus is a Healthcare company based in San Francisco, United States, founded in 2014. It has raised $31.2M in total across 2 rounds, most recently a $30.0M Series A round in Dec 2021. Investors include RA Capital Management and Section 32.
Tech & App Stack
9 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2021
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...